Paul J. Gilligan

4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)pyrazolo[1,5-<i>a</i>]-1,3,5-triazine:  A Potent, Orally Bioavailable CRF₁ Receptor Antagonist

Liqi He, Paul J. Gilligan, Robert Zaczek et al. · Journal of Medicinal Chemistry · 2000 · 113 citations · Full text

Receptor Antagonist, Pharmacotherapy, Pharmaceutical Chemistry +16

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine: A corticotropin-releasing factor (hCRF1) antagonist

Paul J. Gilligan, Caryn Baldauf, Anthony J. Cocuzza et al. · Bioorganic & Medicinal Chemistry · 2000 · 83 citations

Non-Peptide Corticotropin-Releasing Hormone Antagonists:  Syntheses and Structure−Activity Relationships of 2-Anilinopyrimidines and -triazines

Argyrios G. Arvanitis, Paul J. Gilligan, Robert J. Chorvat et al. · Journal of Medicinal Chemistry · 1999 · 74 citations · Full text

Use of the suzuki reaction for the synthesis of aryl-substituted heterocycles as corticotropin-releasing hormone (CRH) antagonists

Anthony J. Cocuzza, Dennis R. Chidester, Steven Culp et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 72 citations · Full text

Suzuki Reaction, Medicinal Chemistry, Heterocyclic +10

Corticotropin-Releasing Hormone Receptor Antagonists:  Framework Design and Synthesis Guided by Ligand Conformational Studies

C. Nicholas Hodge, Paul E. Aldrich, Zelda R. Wasserman et al. · Journal of Medicinal Chemistry · 1999 · 69 citations · Full text

Crh1 Receptor Antagonists, Receptor-bound Conformation, Chemical Biology +20